- OncoSec Medical (NASDAQ:ONCS +0.2%) FQ4 results: Revenues: $0; R&D Expense: $3.8M (+100.0%); SG&A: $2.7M (+58.8%); Net Loss: ($6.5M) (-80.6%); Loss Per Share: ($0.48) (-60.0%).
- FY2015 results: Revenues: $0; R&D Expense: $13.1M (+125.9%); SG&A: $8.1M (+30.6%); Net Loss: ($21.2M) (-76.7%); Loss Per Share: ($1.67) (-32.5%); Quick Assets: $32M (-15.6%).
- No guidance given.
OncoSec Medical reports FQ4 and FY15 results
Recommended For You
More Trending News
About ONCSQ Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ONCSQ | - | - |
OncoSec Medical Incorporated |